Výpis publikací

2007

1. Genetic lesions in multiple myeloma: prognostic and predictive significance in the era of the new drugs

   HÁJEK, Roman, Petr KUGLÍK, Romana ZAORALOVÁ, Henrieta GREŠLIKOVÁ, Pavel NĚMEC a Jana SMEJKALOVÁ. Genetic lesions in multiple myeloma: prognostic and predictive significance in the era of the new drugs. In Blood Reviews, 2007; Vol. 21, Suppl.1. 2007. ISSN 0268-960X.

   Podrobněji: https://is.muni.cz/publication/752162/cs
2. Newly Diagnosed Multiple Myeloma Patients with 1q21 Amplification Treated by Autologous Stem Cell Transplantation Have Shorter Progression-Free Survival Interval

   NĚMEC, Pavel, Henrieta GREŠLIKOVÁ, Petr KUGLÍK, Hana FILKOVÁ, Romana ZAORALOVÁ, Vladimíra VRANOVÁ, Jana SMEJKALOVÁ, Petra VIDLÁKOVÁ, Alexandra OLTOVÁ a Roman HÁJEK. Newly Diagnosed Multiple Myeloma Patients with 1q21 Amplification Treated by Autologous Stem Cell Transplantation Have Shorter Progression-Free Survival Interval. In Blood 2007, Vol.110(11) Part 2. Washington DC, USA: American Society of Hematology (ASH), 2007, s. 263B-263B, 1 s. ISSN 0006-4971.

   Podrobněji: https://is.muni.cz/publication/752135/cs
3. Prognostic impact of 1q21 amplification for newly diagnosed and relapsed/refractory multiple myeloma patients enrolled in Brno, Czech Republic.

   NĚMEC, Pavel, Petr KUGLÍK, Hana FILKOVÁ, Henrieta GREŠLIKOVÁ, Romana ZAORALOVÁ, Jana SMEJKALOVÁ, Alexandra OLTOVÁ a Roman HÁJEK. Prognostic impact of 1q21 amplification for newly diagnosed and relapsed/refractory multiple myeloma patients enrolled in Brno, Czech Republic. In From cell sorting to plasma cell identification and detection chromosomal aberrations in multiple myeloma. Abstract and Application Manual. Brno, Czech Republic: Masaryk University, 2007, s. 9-11. ISBN 978-80-210-4417-3.

   Podrobněji: https://is.muni.cz/publication/726970/cs
4. Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy

   NĚMEC, Pavel, Petr KUGLÍK, Vladimíra VRANOVÁ, Romana ZAORALOVÁ, Henrieta GREŠLIKOVÁ, Alexandra OLTOVÁ, Hana FILKOVÁ, Petra VIDLÁKOVÁ, Jana SMEJKALOVÁ a Roman HÁJEK. Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy. In Blood Reviews. Volume 21, Supplement 1. Neuveden: Elsevier, 2007, s. 131-131. ISSN 0268-960X.

   Podrobněji: https://is.muni.cz/publication/726953/cs